A case of severe reversible lung disease caused by sulphasalazine.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 10665141)

Published in Int J Clin Pract on February 24, 2000

Authors

S Manchanda1, P J Rees

Author Affiliations

1: Department of Thoracic Medicine, Guy's Hospital, London, UK.

Articles by these authors

Hyperbaric oxygen therapy. BMJ (1998) 2.49

An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect (1998) 2.10

Premedication for fibreoptic bronchoscopy. Thorax (1983) 1.91

The importance of particle size in response to inhaled bronchodilators. Eur J Respir Dis Suppl (1982) 1.80

Amiodarone pneumonitis: no safe dose. Respir Med (1995) 1.58

Theophyllines in the treatment of asthma. Br J Clin Pract (1991) 1.39

A new method for computer-assisted determination of airways resistance. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.34

Guidelines for the management of asthma in adults. BMJ (1990) 1.31

Electrophoretic separation of influenza virus ribonucleoproteins. J Gen Virol (1981) 1.27

Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. Chest (1997) 1.24

Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 1.21

Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol (2001) 1.21

Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J (2000) 1.12

Pharmacokinetics of oral acyclovir (Zovirax) in the eye. Br J Ophthalmol (1984) 1.12

Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J (1996) 1.10

A comparison of the refractory periods induced by hypertonic airway challenge and exercise in bronchial asthma. Am Rev Respir Dis (1987) 1.05

Assessment of antitussive effects by citric acid threshold. Br J Dis Chest (1983) 1.02

Airway responses to hypertonic saline, exercise and histamine challenges in bronchial asthma. Eur Respir J (1989) 1.00

Provision of oxygen at home. BMJ (1998) 1.00

The morphology of staphylococcal bacteriophage K and DNA metabolism in infected Staphylococcus aureus. J Gen Virol (1981) 0.99

Sleep apnoea in diabetic patients with autonomic neuropathy. J R Soc Med (1981) 0.99

Home nebulisers for airflow limitation. Br Med J (Clin Res Ed) (1985) 0.96

Role of histamine release in hypertonic saline induced bronchoconstriction. Thorax (1989) 0.96

Acromegaly and narcolepsy. Lancet (1979) 0.95

Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration. Br J Ophthalmol (1986) 0.95

Computer assisted learning is an effective way of teaching endocrinology. Clin Endocrinol (Oxf) (2001) 0.95

Effect of changes in inspiratory flow rate on cough responses to inhaled capsaicin. Clin Sci (Lond) (1991) 0.94

Exertion-induced haemoptysis. Lancet (1993) 0.94

Simple device for laryngeal anesthesia at fibreoptic bronchoscopy. Lancet (1982) 0.93

Kinetics of synthesis of influenza virus ribonucleoprotein structures. J Gen Virol (1982) 0.92

Hepatotoxicity of dextropropoxyphene. Br Med J (1977) 0.91

Effects of histamine on lung permeability in normal and asthmatic subjects. Thorax (1985) 0.91

Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration. Br J Ophthalmol (1985) 0.91

Effects of pholcodine and salbutamol on citric acid induced cough in normal subjects. Thorax (1986) 0.89

Oxygen therapy in chronic lung disease. BMJ (1998) 0.89

Tuberculosis: current issues in diagnosis and treatment. Br J Clin Pract (1994) 0.89

Evaluation of methods used to estimate inhaled dose of carbon monoxide. Thorax (1980) 0.88

Use of dry powder inhalers in COPD. Int J Clin Pract (2007) 0.88

Pneumothorax associated with primary bronchial carcinoma. Br J Dis Chest (1980) 0.87

Alveolar macrophage accessory cell function in bronchial asthma. Am Rev Respir Dis (1992) 0.86

A comparison of mediator and catecholamine release between exercise- and hypertonic saline-induced asthma. Am Rev Respir Dis (1988) 0.86

Changes in pulmonary clearance of technetium labelled DTPA during haemodialysis. Thorax (1986) 0.86

Immediate response to cigarette smoke. Thorax (1982) 0.86

Structure and properties of the rapidly sedimenting replicating complex of staphylococcal phage K DNA. J Gen Virol (1983) 0.85

Recurrent deep vein thrombosis, thromboembolic pulmonary hypertension and the 'primary' antiphospholipid syndrome. Clin Exp Rheumatol (1990) 0.85

Importance of inspiratory flow rate in the cough response to citric acid inhalation in normal subjects. Clin Sci (Lond) (1990) 0.85

Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction. Respir Med (1990) 0.84

Airway responsiveness to methacholine after inhalation of nebulized hypertonic saline in bronchial asthma. J Allergy Clin Immunol (1989) 0.83

The relative responsiveness to inhaled leukotriene E4, methacholine and histamine in normal and asthmatic subjects. Eur Respir J (1988) 0.83

Histamine receptors and pulmonary epithelial permeability. Br J Dis Chest (1987) 0.82

Automated system for the measurement of airways resistance, lung volumes, and flow-volume loops. Thorax (1981) 0.80

Pulmonary echinococcosis with chest wall involvement in a patient with no apparent risk factors. J Infect (2001) 0.80

A515U: a prodrug of acyclovir with increased oral bioavailability. J Antimicrob Chemother (1986) 0.79

Peripheral skin necrosis complicating beta-blockade. Br Med J (1979) 0.79

Circulating concentrations of histamine, neutrophil chemotactic activity, and catecholamines during the refractory period in exercise-induced asthma. J Allergy Clin Immunol (1988) 0.79

Unusual course of beryllium lung disease. Br J Dis Chest (1979) 0.78

Irritant effects of cigarette and cigar smoke. Lancet (1982) 0.78

The effects of osmotic challenge on bronchial responsiveness to methacholine in non-asthmatic subjects. Eur Respir J (1990) 0.78

Tiotropium in the management of chronic obstructive pulmonary disease. Eur Respir J (2002) 0.77

A case of Churg-Strauss syndrome: tissue diagnosis established by sigmoidoscopic rectal biopsy. Gut (1996) 0.77

Maximum achievable bronchodilatation in asthma. Respir Med (1989) 0.77

Snoring, not just a social nuisance. Int J Clin Pract (2003) 0.77

High-dose nedocromil sodium as an addition to inhaled corticosteroids in the treatment of asthma. Respir Med (1994) 0.76

Theophylline. Current thoughts on the risks and benefits of its use in asthma. Drug Saf (1993) 0.76

Paroxysmal nocturnal dyspnoea and periodic respiration. Lancet (1980) 0.76

Oral acyclovir in the management of dendritic herpetic corneal ulceration. Br J Ophthalmol (1984) 0.76

Acute exacerbation of upper airway obstruction in acromegaly. Postgrad Med J (1982) 0.75

Risks of chest drain insertion. Int J Clin Pract (2008) 0.75

Pulmonary infiltrates following bone marrow transplantation. Thorax (1994) 0.75

Pneumococcal vaccination in asthma. Int J Clin Pract (2006) 0.75

Use of a single pair of magnetometer coils to monitor breathing patterns in an intensive care unit. Thorax (1980) 0.75

Oral bronchodilators in the control of asthma. Natl Med J India (1996) 0.75

Non-invasive ventilation at home in chronic obstructive pulmonary disease. Int J Clin Pract (2007) 0.75

An unusual cause of falls in an elderly patient. Int J Clin Pract (2000) 0.75

Airway responsiveness to adenosine 5' monophosphate following inhalation of hypertonic saline. Eur Respir J (1989) 0.75

Acute airway changes induced by coughing. Br J Dis Chest (1984) 0.75

Drug treatment of asthma in the 1990s: achievements and new strategies. Drugs (1999) 0.75

Do medical students learn from multiple choice examinations? Med Educ (1986) 0.75

Paroxysmal nocturnal dyspnea in CHF: mechanisms and aminophylline therapy. Am Heart J (1982) 0.75

Long-acting inhaled beta 2-agonists in the management of asthma: recent advances and current recommendations. Int J Clin Pract (1998) 0.75

Inspiratory muscle strength in acute asthma. Chest (2001) 0.75

Assessment of reversibility in patients with chronic airflow obstruction. Br J Clin Pract (1992) 0.75

The effect of oral corticosteroids on bronchodilator responses in COPD. Respir Med (1998) 0.75

Inhaler use in chronic obstructive pulmonary disease. Int J Clin Pract (1997) 0.75

Assessment of changes in airway calibre using the body plethysmograph. Bull Eur Physiopathol Respir (1985) 0.75

Possible person-to-person transmission of aspergillus. Lancet (1993) 0.75

Sleep apnoea: causes, consequences and treatment. Br J Clin Pract (1992) 0.75

Metalloptysis. Eur Respir J (2006) 0.75

Responses to cigarettes of various tar contents. Br J Dis Chest (1982) 0.75

Legionnaires' disease as a hospital-acquired infection. Br J Clin Pract (1996) 0.75

Current treatment of asthma--focus on leukotrienes. Expert Opin Pharmacother (2000) 0.75

Pattern of breathing during cigarette smoking. Clin Sci (Lond) (1981) 0.75

Asthma: current treatment in perspective. Br J Clin Pract Suppl (1987) 0.75